The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000718347
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
8/05/2026
Date registered
Help: Date registered
16/06/2026
Date last updated
Help: Date last updated
16/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
16/06/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Dysglycaemia risk Extrapolated from Trends of Regulatory hormones Obtained from Cord blood of Very Preterm Infants: The DExTROCord Study
Scientific title
Dysglycaemia risk Extrapolated from Trends of Regulatory hormones Obtained from Cord blood of Very Preterm Infants: The DExTROCord Study
Additional trial identifiers [1] 317195 0
Nil known
Universal Trial Number (UTN)
Trial acronym
The DExTROCord Study
Related trial records

Health condition
Health condition(s) studied:
Prematurity 341776 0
Neonatal Hypoglycaemia 341777 0
Neonatal Hyperglycaemia 341778 0
Condition category
Condition code
Reproductive Health and Childbirth 337857 337857 0 0
Complications of newborn
Metabolic and Endocrine 337858 337858 0 0
Other metabolic disorders

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
The DExTROCord Study is a prospective observational cohort study with the aim of determining the relationship between umbilical cord blood hormones of glucose homeostasis and dysglycaemia (hypoglycaemia and hyperglycaemia) in infants born at less than 32 weeks' gestation. The primary aim is to evaluate whether these hormones predict their risk of hypoglycaemia in the first 24 hours of life. The secondary aim of this study is to determine the relationship between these umbilical cord blood hormones and hyperglycaemia in the first 7 days of life.

Umbilical cord blood samples from eligible infants will be collected at birth. These samples are currently not a part of usual care for these infants. The study will employ a waiver of consent approach for the collection, preservation, and temporary storage of these umbilical cord blood samples to ensure that the study population is a representative sample of infants born at less than 32 weeks' gestation.

After obtaining parental consent for their infant to continue participating in the study, the umbilical cord blood sample will be analysed for glucose, insulin, and cortisol levels. Maternal and neonatal data, including serum blood glucose levels for the first 7 days of life of participants, will be collected from their respective electronic medical records. Maternal data include relevant information such as timing of labour and rupture of membranes, diagnosis of fetal growth restriction, diagnosis of gestational diabetes mellitus and management, and diagnosis of chorioamnionitis. Neonatal data include relevant information such as gestational age at birth, birthweight and associated z-score, sex, diagnosis of fetal growth restriction, level of resuscitation required at birth, and management of hypoglycaemia.

The study aims to recruit a minimum of 100 infants over a period of 2 years from a single tertiary neonatal intensive care unit.
Intervention code [1] 333964 0
Early Detection / Screening
Description of the comparator or control
Infants with hypoglycaemia in the first 24 hours of life will be compared with infants without hypoglycaemia in the first 24 hours of life; infants with hyperglycaemia in the first 7 days of life will be compared with infants without hyperglycaemia in the first 7 days of life
Control group
Active

Outcomes
Primary outcome [1] 345309 0
Risk of hypoglycaemia
Timepoint [1] 345309 0
All serum blood glucose level measurements in the first 24 hours of life (as clinically indicated, expected to be minimum 4-6-hourly)
Secondary outcome [1] 461261 0
Risk of hyperglycaemia
Timepoint [1] 461261 0
All serum blood glucose level measurements in the first 7 days of life (as clinically indicated, expected to be minimum 24-48-hourly)
Secondary outcome [2] 461262 0
Maternal risk factors for hypoglycaemia
Timepoint [2] 461262 0
At birth
Secondary outcome [3] 461263 0
Neonatal risk factors for hypoglycaemia
Timepoint [3] 461263 0
Within first 7 days of life
Secondary outcome [4] 462691 0
Maternal risk factors for hyperglycaemia
Timepoint [4] 462691 0
At birth
Secondary outcome [5] 462692 0
Neonatal risk factors for hyperglycaemia
Timepoint [5] 462692 0
Within first 7 days of life

Eligibility
Key inclusion criteria
This study will comprise of inborn infants born at less than 32 weeks’ gestation. All modes of delivery will be included.
Minimum age
0 Hours
Maximum age
0 Hours
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
There is no specific exclusion criteria in this study.

Study design
Purpose
Screening
Duration
Longitudinal
Selection
Defined population
Timing
Prospective
Statistical methods / analysis
The number of admissions of very preterm infants to this tertiary neonatal intensive care unit (NICU) within a 12-month period has previously been estimated to be approximately 200 infants. Accounting for the unpredictability, and often emergent circumstances, of preterm births and the practicalities of the study methods, we are aiming to recruit a minimum of 100 participants over the duration of the study. Based on previous studies, we expect that 15% of preterm infants in the study will become hypoglycaemic in the first 24 hours of life.

Between-groups comparison will be performed using appropriate statistical analyses based on the normality of the data. Groups for comparison include:
- infants born with labour vs infants born without labour
- diagnosis of fetal growth restriction vs no diagnosis of fetal growth restriction
- evidence of clinical chorioamnionitis vs no evidence of clinical chorioamnionitis
- infants with hypoglycaemia in the first 24 hours vs infants without hypoglycaemia in the first 24 hours
- infants with hyperglycaemia in the first 7 days vs infants without hypoglycaemia in the first 7 days

Univariate logistic regression analyses will be performed to determine the predictive value of umbilical cord blood hormones for hypoglycaemia in the first 24 hours of life. These models will be adjusted for clinical characteristics in multivariable logistic regression analyses.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29492 0
Monash Medical Centre - Clayton campus - Clayton
Recruitment hospital [2] 29493 0
Monash Children’s Hospital - Clayton
Recruitment postcode(s) [1] 45809 0
3168 - Clayton

Funding & Sponsors
Funding source category [1] 321777 0
Other
Name [1] 321777 0
Monash Health Pathology
Country [1] 321777 0
Australia
Primary sponsor type
Hospital
Name
Monash Medical Centre
Address
Country
Australia
Secondary sponsor category [1] 324661 0
None
Name [1] 324661 0
Address [1] 324661 0
Country [1] 324661 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320322 0
Monash Health Human Research Ethics Committee A
Ethics committee address [1] 320322 0
Ethics committee country [1] 320322 0
Australia
Date submitted for ethics approval [1] 320322 0
16/09/2024
Approval date [1] 320322 0
19/02/2025
Ethics approval number [1] 320322 0
HREC/110458/MonH-2025-464266(v3)

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150082 0
Dr Ramon Jose (RJ) Seastres
Address 150082 0
Monash Newborn, Monash Children's Hospital, 246 Clayton Road Clayton VIC 3168
Country 150082 0
Australia
Phone 150082 0
+61 423648688
Fax 150082 0
Email 150082 0
Contact person for public queries
Name 150083 0
Ramon Jose (RJ) Seastres
Address 150083 0
Monash Newborn, Monash Children's Hospital, 246 Clayton Road Clayton VIC 3168
Country 150083 0
Australia
Phone 150083 0
+61 423648688
Fax 150083 0
Email 150083 0
Contact person for scientific queries
Name 150084 0
Ramon Jose (RJ) Seastres
Address 150084 0
Monash Newborn, Monash Children's Hospital, 246 Clayton Road Clayton VIC 3168
Country 150084 0
Australia
Phone 150084 0
+61 423648688
Fax 150084 0
Email 150084 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Study protocol    DExTROCord - Research Protocol.pdf
Ethical approval    2. HREC Review Approval Letter (19 February 2025).pdf
Ethical approval    3. SSA Application Approval Letter (14 May 2025).pdf
Informed consent form    DExTROCord - Participant Information Sheet.pdf


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.